Rhythm Pharmaceuticals, Inc.
RYTM • NASDAQ
Rhythm Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Meeker, with a market cap of $5.8B.
Market Cap$5.8B
Employees226.0
CEODavid Meeker
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Rhythm Pharmaceuticals, Inc. FAQ
Common questions about Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026 before market open. Analysts estimate revenue of $55.8M.
Rhythm Pharmaceuticals, Inc. has approximately 226 employees.